The management of hyperfunctional facial lines with botulinum toxin: A collaborative study of 210 injection sites in 162 patients

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 4, 1997, Pages 389-392

  Blitzer, Andrew ^a,e   Binder, William J ^b   Aviv, Jonathan E ^d   Keen, Monte S ^d   Brin, Mitchell F ^c  

^a Head and Neck Surgical Group   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSTONIA; FACE DISORDER; FACE MUSCLE; FEMALE; HUMAN; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE;

EID: 0030963474     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archoto.123.4.389     Document Type: Article

References (32)

1. Brin MF, Fahn S, Moskowitz C, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord. 1987; 2:237-254.
2. Kang U, Greene P, Fahn S, et al. Double-blind placebo-controlled study of botulinum toxin injection for torticollis. Neurology. 1988;38:244.
3. Brin MF, Fahn S, Moskowitz CB, Blitzer A, Friedman A, Shale HM. Injections of botulinum toxin for the treatment of focal dystonia. Neurology. 1986;36(suppl 1):176.
4. Brin MF, Fahn S, Moskowitz CB, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord. 1987; 2:237-254.
5. Blitzer A, Brin M, Fahn S, Lovelace RE. The use of botulinum toxin in the treat-ment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope. 1988;98: 193-197.
6. Blitzer A, Brin MF, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol. 1989;98:93-97.
7. Brin MF, Blitzer A, Fahn S, Lovelace RE. Adductor laryngeal dystonia: treatment with local injections of botulinum toxin (Botox). Mov Disord. 1988;4: 287-296.
8. Brin MF, Blitzer A, Fahn S, et al. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Mov Disord. 1989;4:287-296.
9. Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol. 1991;100:85-90.
10. Blitzer A, Brin MF, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol. 1989;98:93-97.
11. Blitzer A, Brin MF, Stewart C, Fahn S. Abductor laryngeal dystonia: a series treated wild botulinum toxin. Laryngoscope. 1992;102:163-167.
12. Blitzer A, Brin MF, Fahn S. Botulinum toxin injections for lingual dystonia. Laryngoscope. 1991;101:799.
13. Blitzer A, Brin MF, Keen MS, Aviv JS. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg. 1993;119: 1018-1023.
14. Keen MS, Blitzer A, Aviv JE, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double blind placebo controlled study. Plast Reconstr Surg. 1994;94:94-99.
15. Keen M, Kopelman JE, Aviv JE, Binder W, Brin MF, Blitzer A. Botulinum toxin A: a novel method to remove periorbital wrinkles. Facial Plast Surg. 1994;10: 141-146.
16. Carruthers A, Carruthers J. Aesthetic indications for botulinum toxin injections. Plast Reconstr Surg. 1995;95:427-428.
17. Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev. 1981;33:155-188.
18. Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther. 1980; 212:16-21.
19. Simpson LL, Dasgupta BR. Botulinum neurotoxin type E: studies on mechanism of action and on structure activity relationships. J Pharmacol Exp Ther. 1983;224:135-140.
20. 125I-labelled botulinum neurotoxins with nerve terminals, I: ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol. 1986;103:521-534.
21. National Institutes of Health Consensus Development Conference. Clinical Use of Botulinum Toxin. Bethesda, Md: National Institutes of Health; 1990; 8:1-20.
22. Hambleton P, Moore AP. Botulinum neurotoxins: origin, structure, molecular actions, and antibody. In: Moore P, ed. Handbook of Botulinum Toxin Treatment Boston, Mass: Blackwell Scientific Publications Inc; 1995:16-27.
23. Tosoy EA, Bukley EG. Treatment of blepharospasm with botulinum toxin. Am J Ophthalmol. 1985;99:176.
24. Scott AB, Kennedy RA, Stubbs HA. Botulinum toxin A injection is a treatment for blepharospasm. Arch Ophthalmol. 1984;103:347.
25. Maoriello JA Jr. Blepharospasm Meige's syndrome and hemifacial spasm: treatment with botulinum toxin. Neurology. 1985;35:1499.
26. Borodic GE, Ferranter R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuro-Ophthalmol. 1992;12:121-127.
27. Scott AB, Kennedy RA, Stubbs HA. Botulinum toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103:347-350.
28. Borodic G, Johnson E, Goodnough M, Schantz E. Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology. 1996; 46:26-29.
29. Newmank S, Dolsky R, Nguyen A. Facial profile plasty by liposuction extraction. Otolaryngol Head Neck Surg. 1988;98:718-731.
30. Pitanguy I. Indications for treatment of frontal and glabellar wrinkles in an analysis of 3,404 consecutive cases of rhytidectomy. Plast Reconstr Surg. 1981; 67:157-166.
31. Pollack SV. Silicone, fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol. 1990;16:957-961.
32. Lange DH, Rubin M, Greene PE, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve. 1991;14:672-675.